Results 101 to 110 of about 33,674 (168)

Influenza disease burden in adults by subtypes following the initial epidemic of pandemic H1N1 in Singapore.

Influenza and other respiratory viruses, 2011
Peaks of influenza activity in July 2009 and January 2010 were >90% pandemic H1N1 (pH1N1), but by May 2010, H3N2 predominated in hospital attendances (46·5%, versus 38·9% pH1N1); H3N2 hospital attendances were older (72·9% aged ≥60 years versus 13·5% for pH1N1), but the age-stratified proportions admitted for pneumonia ]were similar.
Win, M.K., Chen, M.I.-C., Barkham, T., Lin, C., Tan, A., Lin, R., Leo, Y.-S.   +6 more
openaire   +2 more sources

The 2009 influenza A virus subtype H1N1 pandemic, a glance from Greece.

Le infezioni in medicina, 2017
The 2009 influenza A - subtype H1N1 pandemic tested the public health care systems all around the globe, infecting millions and leading to thousands of deaths. Greece became the epidemic centre of the 2009 flu pandemic due to the low compliance of the general population towards the vaccination programme, the resistance acquired against antiviral drugs ...
Gregory, Tsoucalas, Markos, Sgantzos
openaire   +1 more source

Poster Sessions

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Profiling lipid mediators in serum from children with H1N1 influenza

Scientific Reports
Influenza A virus subtype H1N1 can cause severe acute respiratory distress syndrome and death in young children and elderly individuals. H1N1 initiates inflammatory responses that aim to contain and eliminate microbial invaders.
Weijun Chen, Yitao Gu, Yongjun Ma, Lele Dong, Liangxuan Pan, Chai Ji, Lanlan Guo, Lianxin Qi, Yuanyuan Zhang, Fei Gao   +9 more
doaj   +1 more source

Influenza Vaccination Effectiveness Against Influenza-Associated Hospitalization in Children and the Effects of Repeated Vaccination. [PDF]

J Infect Dis
Yu X, Lee SL, Kwan MYW, Zhong S, Murphy C, Chan ELY, Wong JSC, Sullivan SG, Peiris M, Cowling BJ.   +9 more
europepmc   +1 more source

ShinyVar: a web-based application for comparative Influenza variant analysis supporting structure-guided approaches to vaccine and antiviral drug design. [PDF]

PeerJ
Lee D, Sangket U.
europepmc   +1 more source

Cross-reactive H5N1 Neuraminidase Antibodies by Age and Influenza A Imprinting Cohorts of the Past Century: Population-Based Serosurvey, British Columbia, Canada. [PDF]

J Infect Dis
Skowronski DM, Ranadheera C, Kaweski SE, Sabaiduc S, Separovic L, Makowski G, Ung J, Reyes RC, Henry B, Albert A, Clemens F, Kobasa D, Bastien N.   +12 more
europepmc   +1 more source

Measuring population immunity against influenza using individual antibody titres: a multicountry, retrospective observational study. [PDF]

Lancet Infect Dis
Xiong W, Huang X, Thao TTN, Thanh NTL, Peng L, Perera RAPM, Fang VJ, Yang B, Wong SS, Leung NHL, Sullivan SG, Ip DKM, Peiris M, Ross TM, Boni MF, Cowling BJ, Tsang TK.   +16 more
europepmc   +1 more source

Human-Origin Influenza A(H3N2) Viruses Revealed in Swine Farms During the Period 2022-2025 in Kazakhstan. [PDF]

Animals (Basel)
Klivleyeva N, Glebova T, Saktaganov N, Baimukhametova A, Kalkozhayeva M, Ongarbayeva N, Ibragimova I, Ibragimov P, Webby R.   +8 more
europepmc   +1 more source